CHI3L1 and early-onset autosomal dominant Alzheimer disease: Connolly et al. proposed the hypothesis that CHI3L1, functioning as a signaling molecule, exerts multiple effects and mediates various neuroinflammatory responses and functional impairments in brain cells, thereby promoting neurodegeneration and triggering degenerative diseases of the nervous system, encompassing ALS and Alzheimer’s disease (AD).